Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| M&g Investment Management | 18B | $31M | 21% | Dec 2023 |
|
| M&G | 18B | $31M | 100% | Mar 2024 |
|
| Calamos Advisors | 64M | $62M | 0% | Mar 2024 |
|
| Wolverine Asset Management | 51M | $50M | 0% | Mar 2024 |
|
| MacKay Shields | 45M | $44M | -1% | Mar 2024 |
|
| Polar Securities | 20M | $20M | 0% | Mar 2024 |
|
| CNH Partners | 14M | $13M | 65% | Mar 2024 |
|
| Millennium Management | 14M | $13M | -13% | Mar 2024 |
|
| Absolute Investment Advisers | 11M | $11B | 0% | Mar 2024 |
|
| Citadel Advisors | 10M | $9.8M | -70% | Mar 2024 |
|
| Kohlberg Kravis Roberts & Co | 10M | $9.7M | -23% | Mar 2024 |
|
| SSI Investment Management | 9.8M | $9.1M | -9% | Dec 2023 |
|
| Morgan Stanley | 9.2M | $9.0M | -8% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.7M | $8.5M | 9% | Mar 2024 |
|
| Amundi | 8.0M | $7.5M | 0% | Mar 2024 |
|
| Wells Fargo & Company | 8.0M | $7.8M | 138% | Mar 2024 |
|
| Bank of America Corporation | 6.9M | $6.7M | 60% | Mar 2024 |
|
| Shenkman Capital Management | 5.5M | $5.5B | 6% | Mar 2024 |
|
| BlackRock | 5.5M | $5.3M | -53% | Mar 2024 |
|
| New York State Common Retirement Fund | 5.0M | $4.9M | 5% | Mar 2024 |
|
| Ofi Invest Asset Management | 4.9M | $9.2M | 111375% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 4.5M | $4.4M | -32% | Mar 2024 |
|
| RWC Asset Management | 4.0M | $3.9M | -25% | Mar 2024 |
|
| Susquehanna International | 4.0M | $3.9M | 233% | Mar 2024 |
|
| Royal Bank of Canada | 3.6M | $3.5M | -8% | Mar 2024 |
|
| Palisade Capital Management | 3.6M | $3.5M | -7% | Mar 2024 |
|
| Man Group | 3.6M | $3.5M | -7% | Mar 2024 |
|
| Franklin Resources | 3.4M | $3.3M | 100% | Mar 2024 |
|
| Credit Suisse | 3.1M | $3.1M | 31% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.6M | $2.5M | -23% | Mar 2024 |
|
| Flossbach Von Storch | 2.5M | $2.5M | 0% | Mar 2024 |
|
| Sonora Investment Management Group | 2.3M | $2.3M | 100% | Mar 2024 |
|
| Leucadia National Corporation | 1.7M | $1.6M | -83% | Mar 2024 |
|
| Agf Management | 1.5M | $1.5M | 36% | Mar 2024 |
|
| Jane Street | 1.4M | $1.3M | -64% | Mar 2024 |
|
| Groupama Asset Managment | 1.2M | $1.1M | 100% | Mar 2024 |
|
| Prospector Partners | 1.0M | $972k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 820k | $799k | -58% | Mar 2024 |
|
| Aviva | 750k | $729k | -25% | Mar 2024 |
|
| Bank of New York Mellon | 600k | $585k | 0% | Mar 2024 |
|
| Zurcher Kantonalbank | 500k | $486k | 0% | Mar 2024 |
|
| Russell Investments | 428k | $418k | 100% | Mar 2024 |
|
| Calamos Wealth Management | 353k | $344k | 23% | Mar 2024 |
|
| Sei Investments | 322k | $313k | 0% | Mar 2024 |
|
| Barclays | 277k | $269k | -91% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 233k | $228k | 100% | Mar 2024 |
|
| Citigroup | 226k | $220k | -79% | Mar 2024 |
|
| KBC Group NV | 200k | $195k | 0% | Mar 2024 |
|
| Oppenheimer Asset Management | 108k | $105k | -45% | Mar 2024 |
|
| Stephens | 104k | $101k | 131% | Mar 2024 |
|
| First Hawaiian Bank | 90k | $87k | -55% | Mar 2024 |
|
| Virtus Investment Advisers | 38k | $37k | 100% | Mar 2024 |
|
| Balboa Wealth Partners | 33k | $32k | 0% | Mar 2024 |
|
| SG Americas Securities | 22k | $2.2M | -43% | Mar 2024 |
|
| Aurum Wealth Management Group | 11k | $10k | 100% | Dec 2023 |
|
| Brian McDonald | 2.0k | $1.9k | -33% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 1.4k | $1.4M | -65% | Mar 2024 |
|
| Context Capital Management | 1.0k | $976k | -100% | Mar 2024 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 82M | $77B |
| Bank Of Montreal | Dec 2023 | 14M | $13M |
| D. E. Shaw & Co | Dec 2023 | 12M | $11M |
| CSS | Dec 2023 | 9.0M | $8.4M |
| Readystate Asset Management | Dec 2023 | 8.5M | $7.9M |
| FMR | Sep 2023 | 6.1M | $5.7M |
| Lombard Odier Asset Management | Sep 2023 | 3.8M | $3.6M |
| OZ Management | Dec 2023 | 2.0M | $1.9M |
| Nomura Holdings | Dec 2023 | 11k | $413k |
| Natixis | Sep 2023 | 11k | $10M |
| UBS Group | Dec 2023 | 2.0k | $1.9k |